Form 4: Sanara MedTech Director Eric Major Receives Restricted Stock Grant Under Incentive Plan

Sanara MedTech Inc. Director Eric Major was granted 3,277 shares of restricted common stock, vesting by May 22, 2026, as part of the company's 2024 Omnibus Long-Term Incentive Plan.

Summary

• Eric D. Major, a Director of Sanara MedTech Inc. (SMTI), was granted 3,277 shares of the company's common stock.
• The transaction occurred on May 22, 2025, with a price of $0 per share, indicating a grant rather than a purchase.
• These shares are restricted stock, issued under the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan.
• The shares will vest on the earlier of the 2026 annual shareholder meeting or May 22, 2026, contingent on Mr. Major continuing to provide services to the company through such date.
• Following this transaction, Mr. Major beneficially owns a total of 9,386 shares of Sanara MedTech Inc. common stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is a positive sign of continued alignment and commitment, although it represents minor dilution. It's a standard compensation practice and generally viewed as a neutral to slightly positive event.

Positives

• The grant of restricted stock aligns the director's long-term interests with those of the shareholders, incentivizing sustained performance.
• It indicates continued commitment and retention of a key director within the company's leadership.
• The grant is part of a formal, pre-approved incentive plan (Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan), reflecting structured compensation practices.

Negatives

• The issuance of new shares, even as restricted stock, at a $0 price represents a minor dilutive effect on existing shareholders.

Risks

• The vesting of the 3,277 restricted shares is contingent upon Eric D. Major continuing to provide services to Sanara MedTech Inc. through the vesting date, meaning the shares could be forfeited if services cease prematurely.

Future Outlook

The restricted stock grant is designed to incentivize the director's continued service and align his interests with the company's long-term performance, with vesting scheduled for 2026.

Industry Context

Stock grants, particularly restricted stock, are a common form of executive and director compensation in the healthcare technology and medical device industry. These grants are widely used to attract, retain, and incentivize key personnel by aligning their financial interests with the company's long-term success and shareholder value creation.

Comparison to Industry Standards

• The use of restricted stock grants as a component of director compensation is a standard practice across various industries, including healthcare technology, aligning director incentives with long-term company performance.
• The vesting schedule tied to continued service is typical for such grants, ensuring retention and commitment.
• Specific comparable companies, projects, or results are not detailed in this filing, as it focuses on an individual's compensation rather than broader operational or financial outcomes.

Related Party Transactions

• The grant of restricted stock to Eric D. Major, a director of Sanara MedTech Inc., constitutes a related party transaction as it involves compensation to an insider.

Stakeholder Impact

• Shareholders: Experience minor dilution from the issuance of new shares, but potentially benefit from the long-term alignment and incentivized performance of a key director.
• Employees: No direct impact mentioned, but the existence of an Omnibus Long-Term Incentive Plan suggests a broader framework for equity-based employee incentives.

Next Steps

• Continued provision of services by Eric D. Major to Sanara MedTech Inc. to fulfill vesting conditions.
• Vesting of the 3,277 restricted shares on the earlier of the 2026 annual shareholder meeting or May 22, 2026.

Key Dates

Recommendation

Keywords

Sanara MedTech Inc., SMTI, Eric D. Major, Restricted Stock, Stock Grant, Director Compensation, SEC Form 4, Insider Transaction, Equity Incentive Plan, Corporate Governance